These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 1689520)
41. Individual variability in cyclosporin A sensitivity: the assessment of functional measures on CD28-mediated costimulation of human whole blood T lymphocytes. Härtel C; Hammers HJ; Schlenke P; Fricke L; Schumacher N; Kirchner H; Müller-Steinhardt M J Interferon Cytokine Res; 2003 Feb; 23(2):91-9. PubMed ID: 12744774 [TBL] [Abstract][Full Text] [Related]
42. The impact of high lymphocyte sensitivity to glucocorticoids on kidney graft survival in patients treated with azathioprine and cyclosporine. Langhoff E; Ladefoged J Transplantation; 1987 Mar; 43(3):380-4. PubMed ID: 3547794 [TBL] [Abstract][Full Text] [Related]
43. FK506 potently inhibits T cell activation induced TNF-alpha and IL-1beta production in vitro by human peripheral blood mononuclear cells. Sakuma S; Kato Y; Nishigaki F; Sasakawa T; Magari K; Miyata S; Ohkubo Y; Goto T Br J Pharmacol; 2000 Aug; 130(7):1655-63. PubMed ID: 10928971 [TBL] [Abstract][Full Text] [Related]
44. Immunosuppressive activity, lymphocyte subset analysis, and acute toxicity of FK-506 in the rat. A comparative and combination study with cyclosporine. Stephen M; Woo J; Hasan NU; Whiting PH; Thomson AW Transplantation; 1989 Jan; 47(1):60-5. PubMed ID: 2463701 [TBL] [Abstract][Full Text] [Related]
45. Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. Metcalfe SM; Richards FM Transplantation; 1990 Apr; 49(4):798-802. PubMed ID: 1691537 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A. Sigal NH; Lin CS; Siekierka JJ Transplant Proc; 1991 Apr; 23(2 Suppl 2):1-5. PubMed ID: 1712132 [No Abstract] [Full Text] [Related]
47. Additional inhibitory effects of intravenous immunoglobulins in combination with cyclosporine A on human T lymphocyte alloproliferative response in vitro. Schanz U; Hügle T; Gmür J Transplantation; 1996 Jun; 61(12):1736-40. PubMed ID: 8685953 [TBL] [Abstract][Full Text] [Related]
48. Inhibition of T and B lymphocyte proliferation by rapamycin. Kay JE; Kromwel L; Doe SE; Denyer M Immunology; 1991 Apr; 72(4):544-9. PubMed ID: 1709916 [TBL] [Abstract][Full Text] [Related]
49. Activation of PPARgamma enhances in vitro the immunosuppressive effect of cyclosporine on T lymphocytes. Rampino T; Ranghino A; Guidetti C; Gregorini M; Soccio G; Marasà M; Libetta C; Guida G; De Amici M; Dal Canton A Transpl Immunol; 2007 Jul; 18(1):32-6. PubMed ID: 17584600 [TBL] [Abstract][Full Text] [Related]
50. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro. Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954 [TBL] [Abstract][Full Text] [Related]
51. Effect of a novel immunosuppressive agent, FK506, on mitogen-induced inositol phospholipid degradation in rat thymocytes. Fujii Y; Fujii S; Kaneko T Transplantation; 1989 Jun; 47(6):1081-3. PubMed ID: 2472025 [No Abstract] [Full Text] [Related]
52. Inter- and intra-subject variation of the suppression of mitogen-induced proliferation of human lymphocytes by cyclosporin-A: reduction of response with delayed addition may be relevant to timing of therapy. Spiers EM; Beck JS Int J Immunopharmacol; 1991; 13(2-3):245-50. PubMed ID: 2071297 [TBL] [Abstract][Full Text] [Related]
53. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction. Bierer BE; Schreiber SL; Burakoff SJ Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317 [No Abstract] [Full Text] [Related]
54. Effect of interleukin 2 on the immunosuppressive action of cyclosporine. Hess AD Transplantation; 1985 Jan; 39(1):62-8. PubMed ID: 3155579 [TBL] [Abstract][Full Text] [Related]
55. Preoperative identification of high-risk recipients of first kidney transplants by in vitro lymphocyte resistance to immunosuppressive agents. Francis DM; Dumble LJ; Bowes LG; MacDonald IM; Kincaid-Smith P; Clunie GJ Transplant Proc; 1991 Feb; 23(1 Pt 2):1323-4. PubMed ID: 1824896 [No Abstract] [Full Text] [Related]
56. Effects of a novel immunosuppressive agent, FK506, on human B cell activation. Suzuki N; Sakane T; Tsunematsu T Clin Exp Immunol; 1990 Feb; 79(2):240-5. PubMed ID: 1690097 [TBL] [Abstract][Full Text] [Related]
57. Combination of immunosuppressive drugs leaves specific "fingerprint" on gene expression in vitro. Rumberger B; Kreutz C; Nickel C; Klein M; Lagoutte S; Teschner S; Timmer J; Gerke P; Walz G; Donauer J Immunopharmacol Immunotoxicol; 2009 Jun; 31(2):283-92. PubMed ID: 19235537 [TBL] [Abstract][Full Text] [Related]
58. Cyclosporine preserves the anergic state of human T cells induced by costimulation blockade in vitro. Koenen HJ; Fasse E; Joosten I Transplantation; 2005 Aug; 80(4):522-9. PubMed ID: 16123728 [TBL] [Abstract][Full Text] [Related]
59. Influence of FK506 and cyclosporin A on alloantibody production and lymphocyte activation following blood transfusion. Woo J; Propper DJ; Macleod AM; Thomson AW Clin Exp Immunol; 1990 Dec; 82(3):462-8. PubMed ID: 1702375 [TBL] [Abstract][Full Text] [Related]
60. The effects of immunosuppressive drugs on the regulation of activation-induced apoptotic cell death in thymocytes. McCarthy SA; Cacchione RN; Mainwaring MS; Cairns JS Transplantation; 1992 Sep; 54(3):543-7. PubMed ID: 1384186 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]